Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice
Taiji Matsusaka, … , Agnes Fogo, Iekuni Ichikawa
Taiji Matsusaka, … , Agnes Fogo, Iekuni Ichikawa
Published May 15, 1999
Citation Information: J Clin Invest. 1999;103(10):1451-1458. https://doi.org/10.1172/JCI5056.
View: Text | PDF
Article

Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice

  • Text
  • PDF
Abstract

To characterize the mode of action of angiotensin II (Ang II) in cardiac remodeling, we generated chimeric mice that are made of both homozygous Ang II receptor type 1A gene (Agtr1a) null mutant cells and Agtr1a intact cells expressing the lacZ gene (ROSA26). Both Agtr1a null and intact myocytes and interstitial cells independently form areas that are randomly distributed throughout the heart. The distribution of ROSA26 cardiomyocytes overlaps completely with that of Ang II binding, indicating that the majority of Ang II receptors reside on cardiomyocytes. When Ang II (1 ng/g body weight/min) was infused for 2 weeks, mice developed mild to moderate hypertension. The proliferating cardiac fibroblasts identified by bromodeoxyuridine staining were present predominantly in the areas surrounded by Agtr1a intact cardiomyocytes. When control chimeric mice made of wild-type cells and ROSA26 cells (i.e., both carrying intact Agtr1a) were infused with Ang II, fibroblast proliferation was found equally in these cardiomyocyte types. When compared with Agtr1a null mutant chimeras, the control chimeras had more extensive cardiac fibrosis, most prominently in perivascular regions. Therefore, in response to Ang II, cardiac fibroblasts proliferate through both the local and systemic action of Ang II. Importantly, the former is determined by the Ang II receptor of neighboring cardiomyocytes, indicating that a communication between myocytes and fibroblasts plays an important role during Ang II–dependent cardiac remodeling.

Authors

Taiji Matsusaka, Hideyuki Katori, Tadashi Inagami, Agnes Fogo, Iekuni Ichikawa

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
BrdU-positivity ratio in Agtr1a–/–↔ROSA and Agtr1a+/+↔ROSA hearts. The n...
BrdU-positivity ratio in Agtr1a–/–↔ROSA and Agtr1a+/+↔ROSA hearts. The number of BrdU-positive and -negative interstitial cell nuclei in ROSA and non-ROSA cardiomyocyte areas is counted separately in 5 areas of 9 Agtr1a–/–↔ROSA mice and 6 Agtr1a+/+↔ROSA mice. All data obtained from 44 areas for Agtr1a–/–↔ROSA mice and 29 areas for Agtr1a+/+↔ROSA mice are pooled, and the values for BrdU-positivity ratio are shown in bars. Data from the posterior wall of the A9 mouse and the anterior wall of W6, which have no ROSA cardiomyocytes, are not included. NS, not significant.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts